Activation of vascular endothelial cell adhesion molecule expression by sickle blood cells

Pediatric Pathology and Molecular Medicine

Volumn 20, Issue 1, 2001, Pages 47-72

  Brown, M D ^a   Wick, T M ^a   Eckman, J R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell adhesion molecules; E selectin; Endothelial adhesion; Endotheliel activities; ICAM 1; Inflammation; Interleukin 1; Leukocytes; Sickle cell anemia; TNF ; VCAM 1

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; POLYMYXIN B; TUMOR NECROSIS FACTOR; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; BLOOD CLOTTING; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE ADHESIVENESS; HEMOSTASIS; HUMAN; HUMAN CELL; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SICKLE CELL ANEMIA; THROMBOSIS; BIOSYNTHESIS; CELL ADHESION; CELL CULTURE; COMPARATIVE STUDY; CULTURE MEDIUM; DRUG EFFECT; ERYTHROCYTE DISORDER; GENE EXPRESSION REGULATION; GENETICS; KINETICS; METABOLISM; PATHOLOGY; RETICULOCYTE; ULTRASOUND; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; CELL ADHESION; CELLS, CULTURED; COMPARATIVE STUDY; CULTURE MEDIA, CONDITIONED; E-SELECTIN; ENDOTHELIUM, VASCULAR; ERYTHROCYTES, ABNORMAL; GENE EXPRESSION REGULATION; HUMAN; INTEGRIN ALPHA4BETA1; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; KINETICS; LEUKOCYTES; LIPOPOLYSACCHARIDES; POLYMYXIN B; RETICULOCYTES; SONICATION; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0035117938     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15227950150502538     Document Type: Article

References (79)

1. Sickle cell anemia and central nervous system infarction: A neuropathological study
2. Large-vessel occlusion in sickle cell disease: Pathogenesis, clinical consequences, and therapeutic implications
3. Vascular modulation
4. Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures
5. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism for microvascular occlusion in sickle cell disease
6. Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow
7. Microvascular site characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications
8. Sickle cell adherence
9. Demonstration of endothelial adhesion of sickle cells in vivo: A distinct role for deformable sickle cells discocytes
10. Sickle erthrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different
11. Beyond hemoglobin polymerization: The red blood cell membrane and sickle disease pathophysiology
12. Molecular basis of sickle cell-endothelial cell interactions
13. Direct expression and cloning of vascular cell adhesion molecule-1 (VCAM-I), a cytokine-induced endothelial protein that binds to lymphocytes
14. Regulation of vascular cell adhesion molecule I on human dermal microvascular endothelial cells
15. Endotoxinaemia in sickle cell disease
16. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: A potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia
17. Occlusion of large cerebral vassels in sickle-cell anemia
18. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents
19. Periodic transfusions for sickle cell anemia and CNS infarction
20. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease
21. MRI of sickle cell cerebral infarction
22. Cerebral infarction in sickle cell anemia: Mechanism based on CT and MRI
23. Intracranial aneurysms in sickle-cell anemia: Clinical features and pathogenesis
24. Increased circulating endothelial cells in sickle cell crisis
25. Circulating activated endothelial cells in sickle cell anemia
26. Elevated levels of circulating intercellular adhesion molecule-1 (cICAM-I) in sickle cell disease
27. Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy
28. Circulating endothelium as an indication of vascular injury
29. Soluble intercellular adhesion molecule-I in arthritis
30. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis
31. Increased soluble endothelial adhesion molecules in rheumatoid arthritis correlate with circulating cytokines and depletion of CD45RO+ T-lymphocytes from blood stream
32. Role of cytokines in endothelial cell functions
33. Vascular cell adhesion molecule-I mediates lymphocyte adherence to cytokine activated cultured human endothelial cells
34. Identification of an inducible endothelial-leukocyte adhesion molecule
35. Induction by IL-I and interteron-g: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-I)
36. Endothelial-leukocyte adhesion molecules
37. The role of endothelial cells in inflammation
38. Endothelial-leukocyte adhesion molecules in human disease
39. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium
40. Effects of normal and sickle erythrocytes on prostacyclin release by perfused human umbilical cord veins
41. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes
42. Sickle erythrocytes, after sickling, regulate the expression of the endothelium-I gene and protein in human endothelial cells in culture
43. Sickle erythrocytes inhibit human endothelial cell DNA synthesis
44. Short-term contact with sickle erythrocytes inhibits shear-induced elongation of arterial endothelium
45. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria
46. Lipopolysaccharide antagonists
47. Effects of ceU lysis on the rheological behavior red blood ceU suspensions
48. Stimulators of tumour necrosis factor production released by damaged erythrocytes
49. The removal of leukocytes and platelets from whole blood
50. 51Cr-release assay for the estimation of mouse cytotoxins
51. Isolation of plasmodium berghie (malaria) parasites by ammonium chloride lysis of infected erythrocyte
52. Regulation of myeloid blood ceU-endothelial interaction by cytokines
53. Elevated immunoreactive tumor necrois factor and interleukin-I in sickle cell disease
54. Levels of tumor necrosis factor a/cachetin (TNFa) in sera from patients with sickle cell disease
55. Circulating cytokines in sickle cell patients during steady state
56. Interleukin-I and interleukin-I antagonism
57. Endothelial cell and vascular damage in the sickle cell disorders
58. Soluble VCAM-1 levels in symptomatic and asymptomatic sickle cell patients
59. In vitro antibody synthesis by peripheral blood mononuclear cells from patients with sickle cell disease
60. Platelet regulatory prostanoids and platelet release products in sickle cell disease
61. Stroke in a cohort of patients with homozygous sickle cell disease
62. Cerebrovascular accidents in sickle cell disease: Rates and risk factors
63. Role of leukocyte-endothelium adhesion in affecting recovery from ischemic episodes
64. Mortality in sickle cell disease: Life expectancy and risk factors for early death
65. Prediction of adverse outcomes in children with sickle cell disease
66. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent
67. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity
68. Membrane-associated iron
69. Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: A novel pathway involving α4β1 integrin receptors on sickle reticulocytes and fibronectin
70. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow
71. Alpha-4/beta-1 integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1 dependent binding to endothelium
72. In vivo models of leukocyte adherence to endothelium
73. Adhesion molecules - Part I
74. Adhesion molecules - Part II